GDNF — A potential target to treat addiction
- 1 April 2009
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 122 (1) , 9-18
- https://doi.org/10.1016/j.pharmthera.2008.12.001
Abstract
No abstract availableKeywords
This publication has 156 references indexed in Scilit:
- The Neural Cell Adhesion Molecule NCAM Is an Alternative Signaling Receptor for GDNF Family LigandsCell, 2003
- Intravenous TAT-GDNF Is Protective After Focal Cerebral Ischemia in MiceStroke, 2003
- XIB4035, a novel nonpeptidyl small molecule agonist for GFRα-1Neurochemistry International, 2003
- Coordinated Activation of Autophosphorylation Sites in the RET Receptor Tyrosine KinaseJournal of Biological Chemistry, 2002
- Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. III. Agonist and Antagonist Properties at Serotonin, 5-HT1 and 5-HT2, Receptor SubtypesThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Released GFRα1 Potentiates Downstream Signaling, Neuronal Survival, and Differentiation via a Novel Mechanism of Recruitment of c-Ret to Lipid RaftsNeuron, 2001
- Differential regulation of glial cell line-derived neurotrophic factor (GDNF) expression in human neuroblastoma and glioblastoma cell linesJournal of Neuroscience Research, 1999
- Attenuation of Alcohol Consumption by a Novel Nontoxic Ibogaine Analogue (18-Methoxycoronaridine) in Alcohol-Preferring RatsPharmacology Biochemistry and Behavior, 1997
- Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous systemCell and tissue research, 1996
- Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in ratDevelopmental Brain Research, 1995